Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001636282-26-000100 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 6, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
22,500
Total Value
$825,521.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Common Stock | โ | Aug 3, 2026 | Exercise/Conversion | 7,500 | $14.50 | $108,750.00 | 105,494 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Aug 3, 2026 | Sale | 5,100 | $95.21 | $485,571.00 | 100,394 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Aug 3, 2026 | Sale | 2,300 | $96.30 | $221,490.00 | 98,094 | Direct | โ | View Details | |
Chief Financial Officer | Common Stock | โ | Aug 3, 2026 | Sale | 100 | $97.10 | $9,710.00 | 97,994 | Direct | โ | View Details | |
Chief Financial Officer | Stock Option (Right to Buy) | Derivative | Aug 3, 2026 | Exercise/Conversion | 7,500 | $0.00 | $0.00 | 344,857 | Direct | โ | View Details |